Reset
Id
Protein
PTM type
Site
Species
Disease
Cell line
Drug
Regulatory
Confidence score(level)
Ref.
acc0701 SIRT7 ubiquitination unclear human Hepatocellular Carcinoma Hep3B Sorafenib Enhancing 5.0 (High) 37187452
acc0702 SIRT7 ubiquitination unclear human Hepatocellular Carcinoma SNU-449 Sorafenib Enhancing 5.0 (High) 37187452
acc0703 AKT ubiquitination unclear human Gastric Cancer MGC803 Estradiol cypionate Associated 4.0 (Moderate) 37392652
acc0704 AKT ubiquitination unclear human Gastric Cancer SGC7901 Estradiol cypionate Associated 4.0 (Moderate) 37392652
acc0705 beta-catenin ubiquitination unclear human Pancreas Cancer MIA PaCa-2 Niclosamide + Gemcitabine Associated 4.0 (Moderate) 37917550
acc0706 4EBP1 phosphorylation Thr37 human Lung Cancer NCI-H196 Olaparib Impairing 5.0 (High) 30201826
acc0707 4EBP1 phosphorylation Thr37 human Glioblastoma SNB-75 Olaparib Impairing 5.0 (High) 30201826
acc0708 4EBP1 phosphorylation Thr37 human Glioblastoma SF-539 Olaparib Impairing 5.0 (High) 30201826
acc0709 4EBP1 phosphorylation Thr37 human Glioblastoma U87-MG Olaparib Impairing 5.0 (High) 30201826
acc0710 4EBP1 phosphorylation Thr46 human Lung Cancer NCI-H196 Olaparib Impairing 5.0 (High) 30201826
acc0711 4EBP1 phosphorylation Thr46 human Glioblastoma SNB-75 Olaparib Impairing 5.0 (High) 30201826
acc0712 4EBP1 phosphorylation Thr46 human Glioblastoma SF-539 Olaparib Impairing 5.0 (High) 30201826
acc0713 4EBP1 phosphorylation Thr46 human Glioblastoma U87-MG Olaparib Impairing 5.0 (High) 30201826
acc0714 4EBP1 phosphorylation Ser65 human Breast Cancer SK-BR-3 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0715 AKT phosphorylation Ser473 human Breast Cancer SK-BR-3 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0716 4EBP1 phosphorylation Ser65 human Breast Cancer MCF7 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0717 AKT phosphorylation Ser473 human Breast Cancer MCF7 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0718 4EBP1 phosphorylation Ser65 human Breast Cancer HER2-18 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0719 AKT phosphorylation Ser473 human Breast Cancer HER2-18 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0720 4EBP1 phosphorylation Ser65 human Breast Cancer BT474 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0721 AKT phosphorylation Ser473 human Breast Cancer BT474 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0722 4EBP1 phosphorylation Ser65 human Breast Cancer MDA-MB-231 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0723 AKT phosphorylation Ser473 human Breast Cancer MDA-MB-231 MLN0128 + TSA Associated 4.0 (Moderate) 24562770
acc0724 histone H3 acetylation Lys9 human Colorectal Cancer HCT116 5-FU Enhancing 4.5 (High) 28139498
acc0725 AKT phosphorylation Ser473 human Colorectal Cancer HCT116 5-FU Enhancing 5.0 (High) 28139498
acc0726 HSP90 acetylation lys human Breast Cancer SK-BR-3 Trastuzumab Enhancing 5.0 (High) 21082217
acc0727 alpha-tubulin acetylation lys human Breast Cancer SK-BR-3 Geldanamycin Enhancing 5.0 (High) 21082217
acc0728 CCAR2 acetylation Lys human Colorectal Cancer HCT116 Sulforaphane Associated 4.0 (Moderate) 30643017
acc0729 RelA acetylation Lys310 human Breast Cancer MDA-MB-231 BRD4 inhibitor 13a Associated 4.0 (Moderate) 34378541
acc0730 FOXO1 acetylation Lys human Lung Cancer PC9 Depsipeptide + Erlotinib Associated 4.0 (Moderate) 26036758
acc0731 FOXO1 acetylation Lys human Lung Cancer H1650 Depsipeptide + Erlotinib Associated 4.0 (Moderate) 26036758
acc0732 FOXO1 phosphorylation Thr24 human Lung Cancer PC9 Ku0063794 + Erlotinib Associated 4.0 (Moderate) 26036758
acc0733 FOXO1 phosphorylation Thr24 human Lung Cancer H1650 Ku0063794 + Erlotinib Associated 4.0 (Moderate) 26036758
acc0734 FOXO1 phosphorylation Thr24 human Lung Cancer PC9 LY294002 + Erlotinib Associated 4.0 (Moderate) 26036758
acc0735 FOXO1 phosphorylation Thr24 human Lung Cancer H1650 LY294002 + Erlotinib Associated 4.0 (Moderate) 26036758
acc0736 GD3 acetylation unclear human Medulloblastoma RES256 Etoposide Impairing 5.0 (High) 31197190
acc0737 GLDC acetylation Lys514 human Glioblastoma U251 Rapamycin Associated 4.0 (Moderate) 34244482
acc0738 GLDC acetylation Lys514 human Glioblastoma U87 Rapamycin Associated 4.0 (Moderate) 34244482
acc0739 ERalpha methylation unclear human Breast Cancer MCF7 Tamoxifen Associated 4.0 (Moderate) 37458145
acc0740 6PGD methylation Arg324 human Lung Cancer Cisplatin Impairing 5.0 (High) 36815049
acc0741 ENO1 methylation Arg9 human Lung Cancer Cisplatin Impairing 5.0 (High) 36815049
acc0742 ENO1 methylation Arg372 human Lung Cancer Cisplatin Impairing 5.0 (High) 36815049
acc0743 AR acetylation Lys609 human Prostate Cancer C4-2B (R)-9b Associated 4.0 (Moderate) 35704598
acc0744 AR phosphorylation Tyr267 human Prostate Cancer C4-2B (R)-9b Associated 4.0 (Moderate) 35704598
acc0745 AKT phosphorylation Ser473 human Cholangiocarcinoma QBC939 5-FU Enhancing 5.0 (High) 25933112
acc0746 S6 phosphorylation Ser235 human Cholangiocarcinoma QBC939 5-FU Enhancing 5.0 (High) 25933112
acc0747 S6 phosphorylation Ser236 human Cholangiocarcinoma QBC939 5-FU Enhancing 5.0 (High) 25933112
acc0748 AKT phosphorylation Ser473 human Cholangiocarcinoma SK-ChA-1 5-FU Enhancing 5.0 (High) 25933112
acc0749 S6 phosphorylation Ser235 human Cholangiocarcinoma SK-ChA-1 5-FU Enhancing 5.0 (High) 25933112
acc0750 S6 phosphorylation Ser236 human Cholangiocarcinoma SK-ChA-1 5-FU Enhancing 5.0 (High) 25933112